APPLIED DNA SCIENCES INC (APDN) Stock Price, Quote, News and Overview
NASDAQ:APDN - Nasdaq - US03815U4094 - Common Stock - Currency: USD
APDN Quote, Performance and Key Statistics
0.157
0 (-2.91%)
The current stock price of APDN is 0.157 USD. In the past month the price decreased by -21.5%. In the past year, price decreased by -98.79%.
APDN Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 24.36 | 203.70B | ||
| DHR | DANAHER CORP | 28.07 | 151.18B | ||
| A | AGILENT TECHNOLOGIES INC | 25.59 | 38.62B | ||
| IQV | IQVIA HOLDINGS INC | 17.15 | 33.64B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 31.26 | 26.91B | ||
| WAT | WATERS CORP | 31.58 | 22.26B | ||
| ICLR | ICON PLC | 14.39 | 16.63B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 31.25 | 15.27B | ||
| ILMN | ILLUMINA INC | 38.45 | 14.94B | ||
| RVTY | REVVITY INC | 23.23 | 13.85B | ||
| AVTR | AVANTOR INC | 17.3 | 11.78B | ||
| TEM | TEMPUS AI INC | N/A | 10.72B |
Related stock screener links
About APDN
Company Profile
Applied DNA Sciences Inc is a US-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Stony Brook, New York and currently employs 53 full-time employees. The company went IPO on 2001-08-24. Applied DNA Sciences, Inc. is a biotechnology company that develops, and markets deoxyribonucleic acid (DNA) based technology solutions. The firm is utilizing its LinearDNA large-scale polymerase chain reaction (PCR) based manufacturing platform. The Company’s proprietary platform produces large quantities of DNA for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets and for supply chain security, anti-counterfeiting and anti-theft technology purposes. The company also develops PCR-based molecular in vitro diagnostics for covid-19. In addition, under its wholly owned subsidiary, Applied DNA Clinical Labs, LLC, the Company is offering a high-throughput turnkey solution for population-scale Covid-19 testing marketed as safeCircle. safeCircle utilizes the Company’s Covid-19 Diagnostic Tests and is designed to look for infection within defined populations or communities utilizing high throughput testing methodologies.
Company Info
APPLIED DNA SCIENCES INC
50 Health Sciences Drive
Stony Brook NEW YORK 11790 US
CEO: James A. Hayward
Employees: 54
Company Website: https://adnas.com/
Investor Relations: http://adnas.com/adnas_home/investors/
Phone: 16312408800
APPLIED DNA SCIENCES INC / APDN FAQ
What is the stock price of APPLIED DNA SCIENCES INC today?
The current stock price of APDN is 0.157 USD. The price decreased by -2.91% in the last trading session.
What is the ticker symbol for APPLIED DNA SCIENCES INC stock?
The exchange symbol of APPLIED DNA SCIENCES INC is APDN and it is listed on the Nasdaq exchange.
On which exchange is APDN stock listed?
APDN stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for APPLIED DNA SCIENCES INC stock?
6 analysts have analysed APDN and the average price target is 1.53 USD. This implies a price increase of 874.52% is expected in the next year compared to the current price of 0.157. Check the APPLIED DNA SCIENCES INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is APPLIED DNA SCIENCES INC worth?
APPLIED DNA SCIENCES INC (APDN) has a market capitalization of 8.66M USD. This makes APDN a Nano Cap stock.
How many employees does APPLIED DNA SCIENCES INC have?
APPLIED DNA SCIENCES INC (APDN) currently has 54 employees.
What are the support and resistance levels for APPLIED DNA SCIENCES INC (APDN) stock?
APPLIED DNA SCIENCES INC (APDN) has a resistance level at 0.17. Check the full technical report for a detailed analysis of APDN support and resistance levels.
Is APPLIED DNA SCIENCES INC (APDN) expected to grow?
The Revenue of APPLIED DNA SCIENCES INC (APDN) is expected to grow by 48.01% in the next year. Check the estimates tab for more information on the APDN EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy APPLIED DNA SCIENCES INC (APDN) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of APDN, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of APDN, evaluating the profitability, health, valuation and growth aspects
- APPLIED DNA SCIENCES INC (APDN) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- APPLIED DNA SCIENCES INC (APDN) Sales and EPS estimates to see what analysts future expectations are.
- APPLIED DNA SCIENCES INC (APDN) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- APPLIED DNA SCIENCES INC (APDN) Insider and Institutional Ownership to learn about the owners and their transactions.
- APPLIED DNA SCIENCES INC (APDN) Stock Chart to make your own analysis
- APPLIED DNA SCIENCES INC (APDN) Latest news and press-releases to stay up to date.
Does APPLIED DNA SCIENCES INC (APDN) stock pay dividends?
APDN does not pay a dividend.
When does APPLIED DNA SCIENCES INC (APDN) report earnings?
APPLIED DNA SCIENCES INC (APDN) will report earnings on 2025-05-08.
What is the Price/Earnings (PE) ratio of APPLIED DNA SCIENCES INC (APDN)?
APPLIED DNA SCIENCES INC (APDN) does not have a PE ratio as the earnings reported over the last twelve months were negative (-5.72).
What is the Short Interest ratio of APPLIED DNA SCIENCES INC (APDN) stock?
The outstanding short interest for APPLIED DNA SCIENCES INC (APDN) is 13.88% of its float. Check the ownership tab for more information on the APDN short interest.
APDN Technical Analysis
APDN Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to APDN. The financial health of APDN is average, but there are quite some concerns on its profitability.
APDN Financial Highlights
Over the last trailing twelve months APDN reported a non-GAAP Earnings per Share(EPS) of -5.72. The EPS increased by 47.04% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -147.7% | ||
| ROE | -184.96% | ||
| Debt/Equity | 0 |
APDN Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 43% to APDN. The Buy consensus is the average rating of analysts ratings from 6 analysts.
For the next year, analysts expect an EPS growth of 84.69% and a revenue growth 48.01% for APDN